0001567619-21-006090.txt : 20210311
0001567619-21-006090.hdr.sgml : 20210311
20210311161240
ACCESSION NUMBER: 0001567619-21-006090
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210309
FILED AS OF DATE: 20210311
DATE AS OF CHANGE: 20210311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ASAR VINIT K
CENTRAL INDEX KEY: 0001454324
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 21733424
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0306
4
2021-03-09
0
0000722723
HANGER, INC.
HNGR
0001454324
ASAR VINIT K
10910 DOMAIN DRIVE
SUITE 300
AUSTIN
TX
78758
1
1
0
0
President and CEO
Common Stock
2021-03-09
4
F
0
26804
23.46
D
798219
D
Common Stock
2021-03-10
4
S
0
15000
23.2187
D
783219
D
Stock Options (right to buy)
12.77
2027-05-19
Common Stock
159982
159982
D
Reflects payment of tax liability by withholding shares of stock incident to vesting of restricted stock previously issued.
The sale by Mr. Asar was effected automatically upon the satisfaction of certain timing, trading price and other conditions under a trading plan designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. Mr. Asar entered into this trading plan on December 4, 2020 and additional periodic sales may occur under this plan through the end of 2021 if the conditions of the plan are met.
These shares were sold at a range of sale prices from $22.95 to $23.49. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Includes (i) unvested restricted shares totaling 55,791 shares of stock from an initial grant of 55,791 shares of restricted stock which begins to vest on March, 8, 2022; (ii) unvested restricted shares totaling 62,847 shares of stock from an initial grant of 69,705 shares of restricted stock which begins to vest on March 9, 2021; (iii) unvested restricted shares totaling 49,292 shares of stock from an initial grant of 54,670 shares of restricted stock which begins to vest on March 9, 2021; (iv) unvested restricted shares and fully vested shares totaling 59,429 shares of stock from an initial grant of 73,987 shares of restricted stock made on March 8, 2019; [continued in next footnote]
(v) unvested restricted shares and fully vested shares totaling 46,954 shares of stock from an initial grant of 58,456 shares of restricted stock made on March 8, 2019; (vi) unvested restricted shares and fully vested shares totaling 56,786 shares of stock from an initial grant of 80,564 shares of restricted stock made on March 9, 2018; (vii) unvested restricted shares and fully vested shares totaling 57,312 shares of stock from an initial grant of 94,500 shares of restricted stock, 25% of which vested on May 17, 2018 and the remainder of which vested on March 8, 2019, 2020 and 2021 (viii) unvested restricted shares and fully vested shares totaling 38,188 shares of stock from an initial grant of 60,000 shares of restricted stock made on April 29, 2016; [continued in next footnote]
(ix) unvested restricted shares and fully vested shares totaling 47,590 shares of stock from an initial grant of 67,516 shares of restricted stock made on March 9, 2018; (x) fully vested shares totaling 65,566 shares of stock from an initial grant of 95,376 shares of restricted stock made on March 6, 2015; (xi) unvested restricted shares and fully vested shares totaling 36,388 shares of stock from an initial grant of 60,000 shares of restricted stock made on March 8, 2017 (xii) fully vested shares totaling 32,807 shares of stock from an initial grant of 42,390 shares of restricted stock made on March 6, 2015; [continued in next footnote]
(xiii) fully vested shares totaling 13,746 shares of stock from an initial grant of 17,973 shares of restricted stock made on March 7, 2014; (xiv) fully vested shares totaling 21,971 shares of stock from an initial grant of 29,292 shares of restricted stock and performance shares made on March 11, 2013; (xv) fully vested shares totaling 9,917 shares of stock from an initial grant of 17,250 shares of restricted stock and performance shares made on August 27, 2012; (xvi) fully vested shares totaling 19,638 shares of stock from an initial grant of 27,600 shares of restricted stock and performance shares made on March 7, 2012; [continued in next footnote]
(xvii) fully vested shares totaling 9,081 shares of stock from an initial grant of 15,923 shares of restricted stock and performance shares made on March 25, 2011; (xviii) fully vested shares totaling 8,853 shares of stock from an initial grant of 23,000 shares of restricted stock and performance shares made on March 30, 2010; and (xiv) fully vested shares totaling 28,570 shares of stock from an initial grant of 42,680 shares of restricted stock and performance shares made on December 29, 2008.
Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Vinit K. Asar
2021-03-11